En esta página
DYN Dyne Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Jul 29, 2026
$15,20
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$12,43mínimo 52 semanas
$27,31máximo 52 semanas
Capitalización Bursátil (MRQ)
$2.52B
P/E
-4.4
BPA
$-3.47
tus insignias
Rango 52S
$12–$27
Calificación del Analista
BUY
Precio Objetivo
$36
P/E
-4.4
ROE
-57.8%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
DYN Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$15.20
Capitalización Bursátil (MRQ)
$2.52B
P/E
-4.4
BPA
$-3.47
ROE
-57.8%
Rango 52S
$12–$27
DYN Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-3.472021-12-31 → 2025-12-31
Flujo de caja libre$-405M2020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | DYN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -4.4promedio 5A ≈-4.7 | ≈-4.7 | · | · | |
| P/C (MRQ) | 3.6promedio 5A ≈4.1 | ≈4.1 | 4.6 | Sobrevalorado | |
| Precio / FCF (TTM) | -5.2promedio 5A ≈-5.9 | ≈-5.9 | · | · | |
| Precio / Flujo de Caja (TTM) | -5.3promedio 5A ≈-6.0 | ≈-6.0 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 2.6promedio 5A ≈4.1 | ≈4.1 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | DYN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -47.5%promedio 5A ≈-61.2% | ≈-61.2% | -31.7% | Débil | |
| ROE | -57.8%promedio 5A ≈-80.9% | ≈-80.9% | -20.6% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | DYN | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 12.0promedio 5A ≈12.6 | ≈12.6 | 10.1 | Liquidez sólida | |
| Quick Ratio (Ratio Rápido) | 17.6promedio 5A ≈8.7 | ≈8.7 | 8.3 | En línea |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-7.1%
Próximo informe
Nov 02, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Jul 27, 2026 | $-1.08 | $-0.76 | -42.4% |
| 31 de marzo de 2026 | $-0.73 | $-0.78 | 6.5% | |
| 31 de diciembre de 2025 | $-0.76 | $-0.78 | 2.3% | |
| 30 de septiembre de 2025 | $-0.76 | $-0.85 | 10.1% | |
| 30 de junio de 2025 | $-0.97 | $-0.96 | -0.60% | |
| 31 de marzo de 2025 | $-1.05 | $-0.89 | -18.2% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $398M | $281M | $211M | $143M | $121M | $45M | $11M | |
| SG&A Expense | $70M | $62M | $31M | $28M | $29M | $13M | $3M | |
| Operating Expenses | $468M | $344M | $242M | $171M | $150M | $59M | $14M | |
| Operating Income | $-468M | $-344M | $-242M | $-171M | $-150M | $-59M | $-14M | |
| Other Non-op | $22M | $26M | $6M | $3M | $734.0K | $-790.0K | $-1M | |
| Income Tax | $0 | $0 | $0 | · | · | · | · | |
| Net Income | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | $-15M | |
| EPS (Basic) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EPS (Diluted) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · | |
| EBITDA | $-466M | $-342M | $-240M | $-169M | $-149M | $-58M | · |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $893M | $435M | $122M | $172M | $201M | $301M | $15M | |
| Prepaid Expense | $16M | $17M | $6M | $10M | $6M | $4M | $127.0K | |
| Current Assets | $1.13B | $659M | $129M | $266M | $382M | $349M | $15M | |
| PP&E (Net) | $24M | $5M | $5M | $6M | $5M | $2M | $1M | |
| PP&E (Gross) | $33M | $12M | $10M | $10M | $7M | $3M | $2M | |
| Accum. Depreciation | $9M | $7M | $5M | $4M | $2M | $995.0K | $295.0K | |
| Other Non-current Assets | · | · | · | · | · | · | $191.0K | |
| Total Assets | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Accounts Payable | $8M | $7M | $23M | $5M | $4M | $3M | $1M | |
| Current Liabilities | $51M | $42M | $51M | $28M | $29M | $11M | $2M | |
| Capital Leases | $15M | $19M | $23M | $26M | $29M | $0 | · | |
| Total Liabilities | $215M | $61M | $74M | $54M | $57M | $11M | $2M | |
| Long-term Debt | $149M | $0 | · | · | · | · | · | |
| Common Stock | $16.0K | $10.0K | $6.0K | $6.0K | $6.0K | $5.0K | $1.0K | |
| Paid-in Capital | $2.37B | $1.58B | $724M | $650M | $597M | $422M | $6M | |
| Retained Earnings | $-1.40B | $-950M | $-633M | $-397M | $-228M | $-79M | $-20M | |
| AOCI | $475.0K | $6.0K | $0 | $-571.0K | $-269.0K | $-27.0K | · | |
| Stockholders' Equity | $972M | $630M | $91M | $252M | $368M | $342M | $14M | |
| Liabilities + Equity | $1.19B | $691M | $165M | $306M | $426M | $353M | $16M | |
| Shares Outstanding | 164,950,540 | 102,318,629 | 61,468,743 | 55,636,505 | 51,569,381 | 45,076,574 | 2,586,535 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $1M | $700.0K | $271.0K | |
| Stock-based Comp | $46M | $46M | $20M | $15M | $18M | $7M | $26.0K | |
| Other Non-cash | $-5M | $-22M | $26M | $-2M | $11M | $6M | · | |
| Operating Cash Flow | $-403M | $-292M | $-188M | $-154M | $-120M | $-47M | $-12M | |
| CapEx | $2M | $2M | $729.0K | $3M | $4M | $1M | $2M | |
| Investing Cash Flow | $-29M | $-204M | $83M | $87M | $-138M | $-46M | $-2M | |
| Debt Issued | $148M | $0 | $0 | · | · | $10M | · | |
| Net Debt Issued | $148M | · | · | · | · | $10M | · | |
| Stock Issued | $141M | $98M | $52M | $37M | · | · | · | |
| Net Stock Activity | $141M | $98M | · | · | · | · | · | |
| Financing Cash Flow | $890M | $810M | $54M | $37M | $158M | $381M | $20M | |
| Net Change in Cash | $458M | $313M | $-51M | $-29M | $-100M | $289M | $7M | |
| Free Cash Flow | $-405M | $-295M | $-189M | $-157M | $-123M | $-48M | · |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| ROA | -47.5% | -74.1% | -100.1% | -45.9% | -38.3% | -32.1% | · | |
| ROE | -57.8% | -47.5% | -193.9% | -67.0% | -38.2% | -16.8% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 | 31.8 | · | |
| Quick Ratio | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 | 27.4 | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.89 | $6.16 | $1.49 | $4.54 | $7.14 | $7.60 | · | |
| Cash / Share | $5.42 | $4.26 | $1.98 | $3.09 | $3.89 | $6.67 | · | |
| EPS (TTM) | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-446M | $-317M | $-236M | $-168M | $-149M | $-59M | · | |
| Market Cap | $3.23B | $2.41B | $818M | $645M | $613M | $947M | · | |
| P/E | -5.6 | -7.0 | -3.4 | -3.6 | -4.1 | · | · | |
| P/B | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Tangible Book | 3.3 | 3.8 | 9.0 | 2.6 | 1.7 | 2.8 | · | |
| P / Cash Flow | -8.0 | -8.2 | -4.3 | -4.2 | -5.1 | -20.4 | · | |
| P / FCF | -8.0 | -8.2 | -4.3 | -4.1 | -5.0 | -19.9 | · | |
| Earnings Yield | -17.7% | -14.3% | -29.7% | -27.9% | -24.6% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $152M | $101M | $95M | $97M | $99M | $106M | $82M | $93M | $62M | $45M | $55M | $59M | $38M | $35M | $47M | $28M | |
| SG&A Expense | $29M | $24M | $21M | $17M | $17M | $16M | $15M | $13M | $10M | $25M | $7M | $8M | $8M | $8M | $6M | $8M | |
| Operating Expenses | $182M | $125M | $116M | $114M | $116M | $122M | $97M | $106M | $72M | $69M | $62M | $67M | $45M | $42M | $53M | $36M | |
| Operating Income | $-182M | $-125M | $-116M | $-114M | $-116M | $-122M | $-97M | $-106M | $-72M | $-69M | $-62M | $-67M | $-45M | $-42M | $-53M | $-36M | |
| Interest Expense | · | · | · | $3M | $94.0K | · | · | $0 | · | · | · | · | · | · | · | · | |
| Other Non-op | $3M | $4M | $4M | $6M | $5M | $7M | $8M | $9M | $7M | $4M | $2M | $2M | $1M | $894.0K | $451.0K | $200.0K | |
| Net Income | $-179M | $-121M | $-112M | $-108M | $-111M | $-115M | $-90M | $-97M | $-65M | $-66M | $-60M | $-65M | $-44M | $-41M | $-52M | $-36M | |
| EPS (Basic) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EPS (Diluted) | $-1.08 | $-0.73 | $-0.69 | $-0.76 | $-0.97 | $-1.05 | $-0.90 | $-0.96 | $-0.70 | $-0.81 | $-0.99 | $-1.08 | $-0.78 | $-0.80 | $-1.01 | $-0.69 | |
| EBITDA | $-181M | $-125M | · | $-113M | $-115M | $-122M | · | $-105M | $-72M | $-69M | $-62M | $-66M | $-45M | $-42M | $-52M | $-35M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $753M | $893M | $574M | $485M | $472M | $435M | $532M | $608M | $272M | $130M | $168M | $181M | $145M | $136M | $148M | |
| Prepaid Expense | $39M | $49M | $16M | $14M | $14M | $12M | $17M | $13M | $13M | $35M | $10M | $5M | $11M | $10M | $6M | $21M | |
| Current Assets | $938M | $1.02B | $1.13B | $806M | $698M | $690M | $659M | $736M | $792M | $488M | $168M | $213M | $249M | $258M | $298M | $344M | |
| PP&E (Net) | $25M | $24M | $24M | $24M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | $6M | $5M | $6M | |
| PP&E (Gross) | $34M | $33M | $33M | $32M | $13M | $13M | $12M | $11M | $11M | $10M | $10M | $10M | $10M | $9M | $8M | $8M | |
| Accum. Depreciation | $10M | $9M | $9M | $8M | $8M | $7M | $7M | $7M | $6M | $6M | $5M | $4M | $4M | $3M | $3M | $2M | |
| Total Assets | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Accounts Payable | $12M | $11M | $8M | $12M | $14M | $7M | $7M | $6M | $2M | $7M | $4M | $3M | $9M | $919.0K | $7M | $5M | |
| Current Liabilities | $78M | $51M | $51M | $60M | $41M | $34M | $42M | $43M | $30M | $22M | $30M | $20M | $22M | $23M | $26M | $23M | |
| Capital Leases | $15M | $14M | $15M | $16M | $17M | $18M | $19M | $20M | $21M | $22M | $24M | $24M | $25M | $27M | $27M | $28M | |
| Total Liabilities | $292M | $215M | $215M | $175M | $158M | $52M | $61M | $63M | $51M | $44M | $53M | $45M | $47M | $50M | $53M | $51M | |
| Long-term Debt | $199M | $149M | $149M | $99M | $99M | · | $0 | · | · | · | · | · | · | · | · | · | |
| Common Stock | $16.0K | $16.0K | $16.0K | $14.0K | $11.0K | $11.0K | $10.0K | $10.0K | $10.0K | $9.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | |
| Paid-in Capital | $2.40B | $2.38B | $2.37B | $1.98B | $1.75B | $1.73B | $1.58B | $1.57B | $1.54B | $1.18B | $718M | $713M | $683M | $608M | $605M | $601M | |
| Retained Earnings | $-1.70B | $-1.52B | $-1.40B | $-1.28B | $-1.18B | $-1.07B | $-950M | $-860M | $-763M | $-698M | $-566M | $-506M | $-441M | $-358M | $-316M | $-264M | |
| AOCI | $-353.0K | $-137.0K | $475.0K | $496.0K | $252.0K | $241.0K | $6.0K | $478.0K | $-240.0K | $-132.0K | $-13.0K | $-56.0K | $-203.0K | $-983.0K | $-1M | $-930.0K | |
| Stockholders' Equity | $702M | $865M | $972M | $692M | $571M | $669M | $630M | $706M | $775M | $478M | $152M | $207M | $242M | $250M | $287M | $336M | |
| Liabilities + Equity | $994M | $1.08B | $1.19B | $867M | $729M | $721M | $691M | $769M | $826M | $522M | $205M | $251M | $289M | $300M | $340M | $388M | |
| Shares Outstanding | 165,670,880 | 165,201,329 | 164,950,540 | 142,613,248 | 114,338,610 | 113,633,782 | 102,318,629 | 101,753,378 | 100,119,518 | 87,089,649 | 61,322,283 | 61,013,986 | 58,305,480 | 51,906,773 | 51,734,361 | 51,649,423 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $600.0K | $550.0K | $547.0K | $500.0K | $500.0K | $502.0K | $487.0K | $400.0K | $400.0K | $386.0K | $400.0K | $400.0K | $412.0K | $400.0K | $500.0K | $425.0K | |
| Stock-based Comp | $15M | $13M | $11M | $11M | $11M | $13M | $10M | $9M | $7M | $20M | $5M | $5M | $5M | $4M | $3M | $4M | |
| Other Non-cash | · | $-38M | · | · | · | $-4M | · | · | · | $-33M | · | · | $-8M | · | · | $-20M | |
| Operating Cash Flow | $-130M | $-145M | $-112M | $-91M | $-95M | $-106M | $-84M | $-75M | $-55M | $-79M | $-51M | $-56M | $-47M | $-43M | $-31M | $-51M | |
| CapEx | $2M | $221.0K | $484.0K | $395.0K | $60.0K | $981.0K | $1M | $253.0K | $857.0K | $191.0K | $167.0K | $250.0K | $230.0K | $886.0K | $261.0K | $1M | |
| Investing Cash Flow | $-5M | $-2M | $982.0K | $-38M | $7M | $1M | $-16M | $-19M | $11M | $-180M | $13M | $17M | $27M | $52M | $18M | $-2M | |
| Debt Issued | · | · | $49M | $0 | · | · | $0 | $0 | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | $0 | $0 | $0 | $0 | $141M | $0 | $0 | $24M | $74M | $0 | $24M | $28M | · | · | · | |
| Net Stock Activity | · | $0 | · | · | · | $141M | · | · | · | $74M | · | · | · | · | · | · | |
| Financing Cash Flow | $58M | $7M | $431M | $217M | $101M | $141M | $4M | $18M | $380M | $408M | $454.0K | $25M | $29M | $70.0K | $99.0K | $18.0K | |
| Net Change in Cash | $-77M | $-140M | $320M | $89M | $13M | $37M | $-97M | $-76M | $336M | $150M | $-37M | $-14M | $9M | $9M | $-12M | $-53M | |
| Free Cash Flow | · | $-145M | · | · | · | $-107M | · | · | · | $-79M | · | · | $-47M | · | · | $-52M |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.7% | -13.4% | · | -13.2% | -14.3% | -18.6% | · | -19.9% | -12.1% | -16.2% | -23.8% | -21.9% | -13.1% | -10.8% | -13.0% | -8.1% | |
| ROE | -28.0% | -15.8% | · | -15.5% | -16.5% | -20.1% | · | -22.7% | -13.3% | -18.2% | -30.0% | -26.3% | -15.3% | -12.5% | -14.1% | -8.7% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 12.0 | 19.9 | · | 13.5 | 16.8 | 20.4 | · | 17.0 | 26.6 | 21.8 | 5.7 | 10.5 | 11.5 | 11.1 | 11.6 | 14.8 | |
| Quick Ratio | 8.7 | 14.7 | · | 9.6 | 11.7 | 13.9 | · | 12.3 | 20.4 | 12.2 | 4.4 | 8.3 | 8.4 | 6.2 | 5.3 | 6.4 | |
| Interest Coverage | · | · | · | -39.2 | -1231.8 | · | · | · | · | · | · | · | · | · | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.24 | $5.24 | · | $4.85 | $5.00 | $5.89 | · | $6.93 | $7.74 | $5.49 | $2.48 | $3.39 | $4.15 | $4.81 | $5.55 | $6.51 | |
| Cash / Share | $4.08 | $4.56 | · | $4.02 | $4.24 | $4.16 | · | $5.23 | $6.07 | $3.12 | $2.12 | $2.75 | $3.11 | $2.79 | $2.63 | $2.86 | |
| EPS (TTM) | $-3.26 | $-3.15 | · | $-3.68 | $-3.88 | $-3.61 | · | $-3.57 | $-3.60 | $-3.98 | $-3.58 | $-3.39 | $-3.32 | $-3.51 | $-3.54 | $-3.11 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-519M | $-452M | · | $-424M | $-413M | $-367M | · | $-295M | $-258M | $-257M | $-208M | $-189M | $-177M | $-181M | $-182M | $-160M | |
| Market Cap | $3.68B | $3.00B | · | $1.80B | $1.09B | $1.19B | · | $3.65B | $3.53B | $2.47B | $549M | $686M | $672M | $659M | $355M | $498M | |
| P/E | -6.8 | -5.8 | · | -3.4 | -2.5 | -2.9 | · | -10.1 | -9.8 | -7.1 | -2.5 | -3.3 | -3.5 | -3.6 | -1.9 | -3.1 | |
| P/B | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Tangible Book | 5.2 | 3.5 | · | 2.6 | 1.9 | 1.8 | · | 5.2 | 4.6 | 5.2 | 3.6 | 3.3 | 2.8 | 2.6 | 1.2 | 1.5 | |
| P / Cash Flow | · | -20.7 | · | · | · | -11.2 | · | · | · | -31.5 | · | · | -14.3 | · | · | -9.8 | |
| Earnings Yield | -14.7% | -17.4% | · | -29.1% | -40.8% | -34.5% | · | -9.9% | -10.2% | -14.0% | -40.0% | -30.1% | -28.8% | -27.6% | -51.5% | -32.3% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-446M | $-317M | $-236M | $-168M | $-149M |
| EPS Diluido | $-3.47 | $-3.37 | $-3.95 | $-3.23 | $-2.93 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 22.3 | 15.6 | 2.5 | 9.5 | 13.3 |
| Ratio Rápido | 17.6 | 10.3 | 2.4 | 6.1 | 7.0 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-405M | $-295M | $-189M | $-157M | $-123M |
Propietarios institucionales (13F) 260 declarantes · $3.7B total · A fecha de 30 de septiembre de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
260
Valor en tenencia
$3.7B
Nuevas posiciones
46
Posiciones cerradas
27
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 46 (+4 vs trimestre anterior) | 27 (-14 vs trimestre anterior) | 90 (-12 vs trimestre anterior) | 76 (+14 vs trimestre anterior) | -9.6M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $275 500 169 | 12 404 330 | 7,51% | Acciones |
| FMR LLC | $248 907 468 | 11 207 000 | 6,79% | Acciones |
| JANUS HENDERSON GROUP PLC | $247 426 927 | 13 647 376 | 6,75% | Acciones |
| VANGUARD GROUP INC | $219 376 451 | 11 215 565 | 5,98% | Acciones |
| STATE STREET CORP | $165 648 021 | 7 458 263 | 4,52% | Acciones |
| Orbis Allan Gray Ltd | $155 615 298 | 7 006 542 | 4,24% | Acciones |
| Atlas Venture Life Science Advisors, LLC | $151 030 199 | 6 800 099 | 4,12% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $140 166 621 | 6 310 969 | 3,82% | Acciones |
| TCG Crossover Management, LLC | $102 502 348 | 4 615 144 | 2,80% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $89 915 586 | 4 048 428 | 2,45% | Acciones |
| FCPM III SERVICES B.V. | $85 469 766 | 3 848 256 | 2,33% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $83 158 757 | 3 743 427 | 2,27% | Acciones |
| Vestal Point Capital, LP | $74 958 750 | 3 375 000 | 2,04% | Acciones |
| ORBIMED ADVISORS LLC | $71 864 542 | 3 235 684 | 1,96% | Acciones |
| Frazier Life Sciences Management, L.P. | $70 029 951 | 3 153 082 | 1,91% | Acciones |
| ARMISTICE CAPITAL, LLC | $68 567 289 | 3 087 226 | 1,87% | Acciones |
| JPMORGAN CHASE & CO | $67 154 494 | 3 151 656 | 1,83% | Acciones |
| PERCEPTIVE ADVISORS LLC | $59 727 909 | 2 689 235 | 1,63% | Acciones |
| Logos Global Management LP | $56 635 500 | 2 550 000 | 1,54% | Acciones |
| BANK OF AMERICA CORP /DE/ | $49 603 770 | 2 233 398 | 1,35% | Acciones |
| Venrock Adviser, LLC | $48 282 608 | 2 173 913 | 1,32% | Acciones |
| GOLDMAN SACHS GROUP INC | $47 911 301 | 2 157 195 | 1,31% | Acciones |
| Siren, L.L.C. | $47 287 866 | 2 129 125 | 1,29% | Acciones |
| FRANKLIN RESOURCES INC | $45 104 481 | 2 030 819 | 1,23% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $43 221 836 | 1 946 479 | 1,18% | Acciones |
| MPM BIOIMPACT LLC | $42 689 686 | 1 922 093 | 1,16% | Acciones |
| SAMLYN CAPITAL, LLC | $38 972 065 | 1 754 708 | 1,06% | Acciones |
| Sofinnova Investments, Inc. | $36 832 709 | 1 658 384 | 1,00% | Acciones |
| Palo Alto Investors LP | $36 591 441 | 1 647 521 | 1,00% | Acciones |
| Vivo Capital, LLC | $34 591 320 | 1 557 466 | 0,94% | Acciones |
| Aberdeen Group plc | $34 190 829 | 1 539 434 | 0,93% | Acciones |
| Deep Track Capital, LP | $33 315 000 | 1 500 000 | 0,91% | Acciones |
| MARSHALL WACE, LLP | $33 068 847 | 1 488 917 | 0,90% | Acciones |
| Polar Capital Holdings Plc | $28 580 072 | 1 286 811 | 0,78% | Acciones |
| NORTHERN TRUST CORP | $28 386 180 | 1 278 081 | 0,77% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26 700 929 | 1 202 203 | 0,73% | Acciones |
| CITADEL ADVISORS LLC | $25 407 307 | 1 143 958 | 0,69% | Acciones |
| Saturn V Capital Management LP | $23 486 920 | 1 057 493 | 0,64% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $21 964 557 | 988 949 | 0,60% | Acciones |
| NOVO HOLDINGS A/S | $21 330 351 | 960 394 | 0,58% | Acciones |
| Rock Springs Capital Management LP | $20 925 240 | 942 154 | 0,57% | Acciones |
| BRAIDWELL LP | $20 468 692 | 921 598 | 0,56% | Acciones |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $19 414 605 | 874 138 | 0,53% | Acciones |
| BAKER BROS. ADVISORS LP | $18 066 702 | 813 449 | 0,49% | Acciones |
| Fiera Capital Corp | $17 545 656 | 789 989 | 0,48% | Acciones |
| MORGAN STANLEY | $16 573 116 | 746 200 | 0,45% | Acciones |
| Artisan Partners Limited Partnership | $14 653 847 | 659 786 | 0,40% | Acciones |
| RAYMOND JAMES FINANCIAL INC | $12 800 733 | 576 350 | 0,35% | Acciones |
| TD Asset Management Inc | $12 173 568 | 548 112 | 0,33% | Acciones |
| ALGERT GLOBAL LLC | $11 244 323 | 506 273 | 0,31% | Acciones |
Activistas y propietarios del %+ 5 1 tenencia
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Vida Ventures II, LLC, Vida Ventures II-A, LLC, VV Manager II, LLC ×2 presentaciones | 10 de febrero de 2023 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 26 insiders · 11 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| John Cox | CEO & President | 8 de septiembre de 2026 S | 357 507 | 0 | 6 | $-443 688 |
| Joshua T Brumm | CEO & President | 11 de marzo de 2024 M | 537 998 | 0 | 0 | $0 |
| Erick Lucera | Chief Financial Officer | 13 de agosto de 2026 S | 119 766 | 0 | 4 | $-228 675 |
| Susanna Gatti High | Chief Operating Officer | 18 de septiembre de 2024 S | 131 636 | 0 | 0 | $0 |
| Johanna Friedl-Naderer | Chief Commercial Officer | 8 de septiembre de 2026 S | 152 897 | 0 | 7 | $-43 380 |
| Douglas Kerr | Chief Medical Officer | 8 de septiembre de 2026 S | 162 564 | 0 | 7 | $-233 116 |
| Oxana Beskrovnaya | Chief Scientific Officer | 11 de marzo de 2025 S | 195 840 | 0 | 0 | $0 |
| Richard William Scalzo | SVP, Head of Finance & Admin. | 11 de marzo de 2025 S | 122 330 | 0 | 0 | $0 |
| Wildon Farwell | Chief Medical Officer | 19 de agosto de 2024 S | 143 222 | 0 | 0 | $0 |
| Jonathan Mcneill | Chief Business Officer | 19 de agosto de 2024 S | 132 106 | 0 | 0 | $0 |
| Romesh Subramanian | Chief Scientific Officer | 16 de septiembre de 2020 A | 566 249 | 0 | 0 | $0 |
| Jason P Rhodes | Consejero | 14 de agosto de 2026 S | 428 946 | 0 | 79 | $-129 095 799 |
| Dirk Kersten | Consejero | 27 de julio de 2026 S | 3 586 796 | 0 | 19 | $-38 570 974 |
| Barry E Greene | Consejero | 22 de junio de 2026 A | · | 0 | 0 | $0 |
| Carlo Incerti | Consejero | 5 de junio de 2026 A | 0 | 0 | 0 | $0 |
| Catherine Stehman-Breen | Consejero | 5 de junio de 2026 A | 115 713 | 0 | 0 | $0 |
| David Charles Lubner | Consejero | 5 de junio de 2026 A | 0 | 0 | 0 | $0 |
| Brian S Posner | Consejero | 5 de junio de 2026 A | 24 500 | 7 | 0 | $274 840 |
| Edward Hurwitz | Consejero | 5 de junio de 2026 A | 91 081 | 0 | 0 | $0 |
| Vikram Karnani | Consejero | 22 de diciembre de 2025 A | · | 0 | 0 | $0 |
| Lawrence Otto Klein | Consejero | 5 de julio de 2022 A | 10 725 | 0 | 0 | $0 |
| Atlas Venture Fund XI, L.P. | Propietario del 10% | 13 de julio de 2021 J | 7 326 117 | 0 | 0 | $0 |
| CureDuchenne Ventures, LLC | Propietario del 10% | 21 de septiembre de 2020 C | 602 972 | 0 | 0 | $0 |
| Forbion Capital Fund IV Cooperatief U.A. | Propietario del 10% | 21 de septiembre de 2020 C | 6 131 079 | 0 | 0 | $0 |
| Logos Global Management LP | Propietario del 10% | 21 de septiembre de 2020 C | 1 504 392 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 21 de septiembre de 2020 C | 1 608 785 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 41 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IBRN · iShares Trust | 2,55% | 10 352 SH | 11 de septiembre de 2026 | Diario |
| BBC · ETFis Series Trust I | 0,93% | 17 087 NS | 31 de julio de 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,82% | 2 968 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,72% | 140 706 NS | 31 de julio de 2026 | N-PORT |
| ESSC · Strategy Shares | 0,23% | 3 298 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,20% | 1 142 515 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,20% | 1 922 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,20% | 13 206 SH | 1 de octubre de 2026 | Diario |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,15% | 41 341 NS | 31 de julio de 2026 | N-PORT |
| BKSE · BNY Mellon ETF Trust | 0,13% | 4 624 NS | 31 de julio de 2026 | N-PORT |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,13% | 77 375 SH | 19 de agosto de 2026 | Diario |
| RSSL · Global X Funds | 0,12% | 72 365 NS | 31 de julio de 2026 | N-PORT |
| IWM · iShares Trust | 0,09% | 3 869 303 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,09% | 784 894 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,08% | 478 626 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,07% | 37 091 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,06% | 494 945 SH | 11 de septiembre de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,06% | 50 849 SH | 19 de agosto de 2026 | Diario |
| ESML · iShares Trust | 0,06% | 83 903 SH | 11 de septiembre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 65 771 NS | 31 de julio de 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 47 064 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 83 235 SH | 1 de octubre de 2026 | Diario |
| VXF · VANGUARD INDEX FUNDS | 0,04% | 1 689 620 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,04% | 347 244 SH | 19 de agosto de 2026 | Diario |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 1 020 875 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,02% | 8 555 SH | 11 de septiembre de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,02% | 1 607 020 SH | 19 de agosto de 2026 | Diario |
| DXUV · Dimensional ETF Trust | 0,02% | 3 800 NS | 31 de julio de 2026 | N-PORT |
| TILT · FlexShares Trust | 0,01% | 12 166 NS | 31 de julio de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 217 916 NS | 31 de julio de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,01% | 14 680 NS | 31 de julio de 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,01% | 37 664 NS | 31 de julio de 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 199 795 SH | 11 de septiembre de 2026 | Diario |
| DFUS · Dimensional ETF Trust | 0,00% | 31 685 NS | 31 de julio de 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 39 299 SH | 11 de septiembre de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4 473 029 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11 370 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 928 355 SH | 11 de septiembre de 2026 | Diario |
| ISCB · iShares Trust | · | 7 751 SH | 11 de septiembre de 2026 | Diario |
| ISCV · iShares Trust | · | 12 245 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 33 057 SH | 11 de septiembre de 2026 | Diario |
DYN Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 21 analistas
COMPRA
Objetivo mediano
$37.00
+143,4%
7 33,3%
Compra fuerte
12 57,1%
Compra
2 9,5%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
15 analistas · 2026-10-03Objetivo medio $36.00 +136,8%
Ahora
Precio Actual $15.20
Mín$10.00
Media$36.00
Máx$50.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| CLDX | $1.81B | -7.0 | -78.0% | -16748.0% | -43.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
| IRON | $3.01B | -13.2 | · | · | -31.3% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Jul 29, 2026